Vigil Neuroscience, Inc. (VIGL) has 16 open-market insider trades by 10 insiders since 2022. The most active filer is Ivana Magovcevic-Liebisch, President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Stefan Vitorovic | Dir | — | 1 | $23.4M | 2025-08-05 |
| Bruce Booth | Dir | — | 1 | $7.5M | 2025-08-05 |
| Northpond Ventures, LP | 10% Owner | — | 1 | $5.0M | 2022-01-11 |
| Clay Thorp | Dir | — | 3 | $3.9M | 2022-05-17 |
| Ivana Magovcevic-Liebisch | Pres | — | 5 | $62K | 2025-08-05 |
| Haeberlein Samantha L. Budd | Dir | — | 1 | $21K | 2025-08-05 |
| Jennifer Lynn Ziolkowski | CFO | — | 1 | $15K | 2025-08-05 |
| Christopher Verni | General Counsel | — | 1 | $15K | 2022-05-03 |
| Spyros Papapetropoulos | Chief Medical Officer | — | 1 | $14K | 2022-11-18 |
| Evan Thackaberry | SVPHead of Early Development | — | 1 | $6K | 2022-05-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Haeberlein Samantha L. Budd | Director | Buy | $21K | 2024-12-19 |
| Ivana Magovcevic-Liebisch | President | Buy | $8K | 2024-12-19 |
| Ivana Magovcevic-Liebisch | President | Buy | $8K | 2024-12-18 |
| Ivana Magovcevic-Liebisch | President | Buy | $12K | 2024-12-05 |
| Ivana Magovcevic-Liebisch | President | Buy | $15K | 2023-11-20 |
| Spyros Papapetropoulos | Chief Medical Officer | Sell | $4K |
Companies that share insiders with VIGL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-11-18 |
| Clay Thorp | Director | Buy | $165K | 2022-05-16 |
| Evan Thackaberry | SVP & Head of Early Development | Buy | $6K | 2022-05-05 |
| Spyros Papapetropoulos | Chief Medical Officer | Buy | $14K | 2022-05-03 |
| Christopher Verni | General Counsel | Buy | $15K | 2022-05-03 |
| Ivana Magovcevic-Liebisch | President | Buy | $18K | 2022-05-02 |
| Clay Thorp | Director | Buy | $22K | 2022-03-28 |
| Stefan Vitorovic | Director | Buy | $23.4M | 2022-01-11 |
| Bruce Booth | Director | Buy | $7.5M | 2022-01-11 |
| Clay Thorp | Director | Buy | $3.7M | 2022-01-11 |